Primary CNS Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
Condition: Central Nervous System Lymphoma Intervention: Drug: lenalidomide Sponsors: Seoul National University Bundang Hospital; Samyang BioPharm Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials
